In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 549.4 | 889.1 | 668.6 | 786.1 | 661.0 | 1,026.7 | 780.1 | 885.2 | 806.9 | 1,126.4 | 970.9 | 1,088.8 | |
| Other Income | 2.0 | 13.0 | 4.4 | 4.6 | 1.8 | 3.4 | 2.3 | 2.9 | 3.4 | 4.0 | 4.7 | 2.7 | |
| Total Income | 551.4 | 902.1 | 673.0 | 790.7 | 662.7 | 1,030.1 | 782.4 | 888.2 | 810.3 | 1,130.3 | 975.6 | 1,091.5 | |
| Expenses | |||||||||||||
| + Purchases of Stock-in-Trade | 476.8 | 470.7 | 532.7 | 365.0 | 679.7 | 565.2 | 690.6 | 404.2 | 761.4 | 623.7 | 697.6 | 620.0 | |
| + Changes in Inventories | -117.5 | 102.6 | -76.0 | 144.4 | -240.8 | 94.3 | -168.7 | 168.6 | -225.9 | 95.4 | -38.8 | 93.6 | |
| + Employee Benefit Expense | 71.3 | 77.2 | 67.0 | 84.1 | 86.5 | 95.3 | 97.4 | 95.0 | 97.6 | 101.8 | 100.5 | 111.2 | |
| + Finance Costs | 35.9 | 37.6 | 35.9 | 37.5 | 39.1 | 42.4 | 17.4 | 18.2 | 17.5 | 20.6 | 19.2 | 19.8 | |
| + Depreciation & Amortisation | 53.2 | 58.3 | 60.7 | 56.8 | 59.2 | 62.6 | 54.4 | 67.9 | 71.1 | 77.9 | 80.1 | 84.0 | |
| + Other Expenses | 118.2 | 118.9 | 104.7 | 93.7 | 96.9 | 100.5 | 92.6 | 91.2 | 102.2 | 96.0 | 105.3 | 103.3 | |
| Total Expenses | 637.8 | 865.2 | 725.0 | 781.4 | 720.7 | 960.4 | 783.7 | 845.2 | 823.9 | 1,015.3 | 964.0 | 1,031.9 | |
| EBITDA | 0.7 | 119.7 | 40.2 | 99.0 | 38.6 | 171.4 | 68.1 | 126.2 | 71.5 | 209.5 | 106.3 | 160.6 | |
| EBIT | -52.5 | 61.4 | -20.5 | 42.2 | -20.6 | 108.8 | 13.8 | 58.3 | 0.4 | 131.6 | 26.1 | 76.7 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | -86.4 | 36.9 | -52.0 | 9.3 | -58.0 | 69.7 | -1.3 | 42.9 | -13.6 | 115.0 | 11.6 | 59.5 | |
| + Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 24.2 | 0.0 | 0.0 | -2.1 | 0.9 | 0.0 | |
| Pretax Income | -86.4 | 36.9 | -52.0 | 9.3 | -58.0 | 69.7 | 22.9 | 42.9 | -13.6 | 112.9 | 12.5 | 59.5 | |
| + Current Tax | 0.0 | 0.0 | -4.5 | 0.4 | -0.4 | 5.8 | -5.7 | 7.0 | -4.5 | 22.7 | -3.4 | 11.7 | |
| + Deferred Tax | -22.3 | 8.7 | -8.5 | -3.2 | -1.1 | -7.6 | 10.1 | 2.4 | -0.2 | 2.2 | 4.7 | 0.6 | |
| Tax Expense | -22.3 | 8.7 | -13.1 | -2.8 | -1.5 | -1.9 | 4.4 | 9.3 | -4.7 | 24.9 | 1.3 | 12.3 | |
| Net Income | -64.1 | 28.2 | -38.9 | 12.1 | -56.5 | 71.6 | 18.5 | 33.6 | -8.9 | 88.0 | 11.3 | 47.2 | |
| + Net Income — Continuing Ops | -64.1 | 28.2 | -38.9 | 12.1 | -56.5 | 71.6 | 18.5 | 33.6 | -8.9 | 88.0 | 11.3 | 47.2 | |
| + Other Comprehensive Income | -0.8 | -0.1 | 1.4 | 0.2 | -2.0 | -0.1 | -0.9 | -0.3 | -0.3 | -0.2 | 0.6 | -0.1 | |
| Total Comprehensive Income | -64.9 | 28.2 | -37.6 | 12.3 | -58.5 | 71.5 | 17.6 | 33.3 | -9.1 | 87.8 | 11.9 | 47.1 | |
| Per Share | |||||||||||||
| Basic EPS | -32.43 | 14.28 | -19.68 | 6.14 | -28.57 | 36.18 | 9.35 | 4.23 | -1.12 | 11.08 | 1.49 | 5.94 | |
| Diluted EPS | -32.43 | 14.20 | -19.68 | 6.11 | -28.57 | 35.82 | 9.25 | 4.21 | -1.12 | 11.03 | 1.48 | 5.91 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | -0.9 | -0.3 | -0.3 | -0.2 | 0.6 | -0.1 | |
| + Items NOT to be Reclassified to P&L | -1.1 | -0.1 | 1.8 | 0.2 | -2.6 | -0.1 | -1.2 | -0.4 | -0.4 | -0.3 | 0.8 | -0.1 | |
| + Tax on Items NOT to be Reclassified | — | — | — | — | — | — | -0.3 | -0.1 | -0.1 | -0.1 | 0.2 | -0.0 | |
| + Tax on Items NOT to be Reclassified — alt tag | -0.3 | -0.0 | 0.5 | 0.1 | -0.7 | -0.0 | — | — | — | — | — | — | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | -32.43 | 14.28 | -19.68 | 6.14 | -28.57 | 36.18 | 9.35 | 4.23 | -1.12 | 11.08 | 1.49 | 5.94 | |
| Diluted EPS — Continuing Operations | -32.43 | 14.20 | -19.68 | 6.11 | -28.57 | 35.82 | 9.25 | 4.21 | -1.12 | 11.03 | 1.48 | 5.91 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 4.8 | — | 2.0 | — | 6.9 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | 190.2 | 315.7 | 211.9 | 276.7 | 222.1 | 367.2 | 258.2 | 312.4 | 271.4 | 407.3 | 312.1 | 375.2 | |
| Gross Margin % | 34.61 | 35.51 | 31.70 | 35.20 | 33.60 | 35.76 | 33.10 | 35.29 | 33.63 | 36.16 | 32.15 | 34.46 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | -86.4 | 36.9 | -52.0 | 9.3 | -58.0 | 69.7 | -1.3 | 42.9 | -13.6 | 115.0 | 11.6 | 59.5 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 24.2 | 0.0 | 0.0 | -2.1 | 0.9 | 0.0 | |
| Net Income Adj (tax-effected) | -64.1 | 28.2 | -38.9 | 12.1 | -56.5 | 71.6 | -1.0 | 33.6 | -8.9 | 89.6 | 10.5 | 47.2 | |
| EPS Adj | -32.43 | 14.28 | -19.68 | 6.14 | -28.57 | 36.18 | -0.53 | 4.23 | -1.12 | 11.29 | 1.38 | 5.94 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Paid Up Equity Capital | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 19.8 | 79.4 | 79.4 | 79.4 | 79.5 | 79.6 | |